期刊文献+

X线立体定位细针活检诊断不可触及的乳腺病变 被引量:3

Evaluation of Stereotactic Mammography Needle Localized Biopsyfor Nonpalpable Breast Lesion
下载PDF
导出
摘要 目的 :探讨乳腺X线立体定位细针活检技术诊断不可触及的乳腺病灶的价值。材料和方法 :对 2 7例临床不能触及 ,而X线片上显示的乳腺微小病变 ,通过X线立体定位穿刺 ,放入钢丝定位后指导外科切检 ,进行组织病理学检查。结果 :2 7个乳腺病变 ,恶性病变 7例 ,其中T0 期 3例 ,T1期 4例 ;良性病变 2 0例 ,含慢性囊性乳腺病 10例 (其中合并导管上皮异型增生及上皮增生活跃各 3例 ) ,小叶增生 3例 ,慢性炎症 3例 ,腺纤维瘤 2例 ,导管内乳头状瘤 1例 ,错钩瘤 1例。结论 :立体定位细针活检对不可触及的乳腺病变的定位定性诊断以及对早期乳腺癌的诊断有重要价值。 Purpose To evaluate the value of stereotactic mammography needle localized biopsy (SNLB)in the diagnosis of nonpalpable breast lesion. Materials and Methods: SNLB was performed on 27 cases with clinical nonpalpable breast lesion.Results:The study showed that breast cancer was in 7 including T0 stage 3, T1 stage 4; benign breast lesion 20, cystic disease 10 combined with 6 atpical hyperplasia, mammary lobule hyperplasia 3, chronoc mastitis 3, fibroadenoma 2, papilloma 1 and hamartoma 1. Conclusion:SNLB is of great sigmificance about location and qualitative determination for diagnosing nonpalpable breast lesion. It can play a significant role in clinical diagnosis of nonpalpabe breast lesion.
出处 《中国医学影像学杂志》 CSCD 2002年第6期408-411,共4页 Chinese Journal of Medical Imaging
基金 广东省卫生厅科研课题 (A2001613)
关键词 不可触及的乳腺病变 X线立体定位 细针活检 诊断 nonpalpabie breast lesion(NPBL) stereotactic mammography needle localized biopsy
  • 相关文献

参考文献7

二级参考文献24

  • 1徐开ye.乳腺疾病影像诊断与治疗学[M].上海:上海科技教育出版社,1996.82-90.
  • 2Homer MJ Smith TJ 等.对不能触及的乳腺病变在门诊用针穿法定位及活检[J].美国医学会杂志:中文版,1985,4(2):87-87.
  • 3李树玲.乳腺癌的早期诊断[J].中国肿瘤临床,1988,15(2):105-105.
  • 4Layfield L J,Cancer,1991年,68卷,2007页
  • 5李树玲,中国肿瘤临床,1988年,15卷,2期,105页
  • 6Homer M J,美国医学会杂志,1985年,4卷,2期,87页
  • 7蔡丰,中华放射学杂志,1997年,31卷,779页
  • 8徐开,乳腺疾病影像诊断与治疗学,1996年,16页
  • 9Pressler V,J Am Coll Surg,1994年,178卷,54页
  • 10Rissanen T J,J Ultrasound Med,1994年,13卷,183页

共引文献101

同被引文献38

  • 1周易冬.不可触及的乳腺病变的诊断[J].中国实用外科杂志,1997,17(4):243-245. 被引量:6
  • 2Cheng HD,Lui YM,Freimanis RI.A novel approach to microcalcification detection using fuzzy logic technique[J].IEEE Trans Med Imaging, 1998, 17 (3):442 - 450.
  • 3Cassano E, Rizzo S, Bozzini A, et al. Contrast enhanced ultrasound of breast cancer [J]. Cancer Imaging, 2006, 6: 4- 6.
  • 4Jatoi I. MRI in breast cancer management: potential for benefit and harm. Int I Fertil Womens[J] .Med,2005, 50 (6): 281-284.
  • 5Echevarria J J, Martin M, Saiz A,et al.Overall breastd ensity in MR mammography: diagnostic and therapeutic implications in breast cancer[J] .J Comput Assist Tomogr, 2006, 30 (1): 140- 147.
  • 6Rankin SC.MRI of the breast[J] .Br J Radiol,2000,73: 806-818.
  • 7Wedegartner U, Bick U, Wortler K, et al.Differentiation between benign and malignant findings on MR-mammography: usefulness of morphological criteria [J].Eur Radiol, 2001,11: 1645- 1650.
  • 8Manton D J, Chaturvedi A, Hubbard A.Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectros copy [J].Br J Cancer, 2006, 94 (3): 427-435.
  • 9Heywang- Kobrunner SH, Bick U, Bradley WG Jr,et al. International investigation of breast MRI: resuits of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions [J] .Eur Radiol, 2001, 11 (4): 531- 546.
  • 10Fajardo LL, De Angelis. The role of stereotacticbiopsy in abnormal mammograms[J] .Surg Oncol Cin N Am, 1997, 6 (2): 295-299.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部